Yahoo España Búsqueda web

Search results

  1. Hace 5 días · La empresa de telesalud Hims ha lanzado un tratamiento basado en compounding que ofrece una alternativa asequible a populares medicamentos para adelgazar, adaptándose a la creciente demanda y...

  2. Hace 5 días · This week, telehealth prescription company Hims & Hers launched an initiative to offer glucagon-like peptide 1 (GLP-1) agonists, a class of medications that includes semaglutide, from a compounded pharmacy at a relatively affordable starting price of $199 a month.

  3. Hace 3 días · Hims & Hers Health ha lanzado medicamentos inyectables GLP-1 para la pérdida de peso a una fracción del costo de marcas como Wegovy y Ozempic, haciendo que sus acciones suban más del 30%.

  4. Hace 6 días · Health platform Hims & Hers Health Inc. announced Monday that it's rolling out injectable weight-loss drugs that cost a fraction of the price of competitors Wegovy and Ozempic.

  5. Hace 5 días · Hims & Hers ( HIMS -5.59%) has been a great growth stock since coming public, but it's now starting to turn a profit. In this video, Travis Hoium highlights the company's financials and why the...

  6. Hace 5 días · The dig­i­tal health com­pa­ny Hims & Hers has start­ed pre­scrib­ing a cheap­er, com­pound­ed ver­sion of a pop­u­lar GLP-1 weight loss drug, a move that ex­perts say could land the com­pa­ny in...

  7. Hace 5 días · A high-level overview of Hims & Hers Health, Inc. (HIMS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.